Cipher Pharmaceuticals Inc banner

Cipher Pharmaceuticals Inc
TSX:CPH

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
TSX:CPH
Watchlist
Price: 14.4 CAD Market Closed
Market Cap: CA$365.3m

Wall Street
Price Targets

CPH Price Targets Summary
Cipher Pharmaceuticals Inc

Wall Street analysts forecast CPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPH is 19.58 CAD with a low forecast of 18.79 CAD and a high forecast of 21 CAD.

Lowest
Price Target
18.79 CAD
30% Upside
Average
Price Target
19.58 CAD
36% Upside
Highest
Price Target
21 CAD
46% Upside
Cipher Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

19% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
19% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Cipher Pharmaceuticals Inc's revenue is 19%. The projected CAGR for the next 3 years is 28%.

Operating Income
Forecast

N/A
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat

The compound annual growth rate of Cipher Pharmaceuticals Inc's operating income for the next 2 years is 68%.

Net Income
Forecast

N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat
N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat

The compound annual growth rate of Cipher Pharmaceuticals Inc's net income for the next 3 years is 21%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CPH's stock price target?
Price Target
19.58 CAD

According to Wall Street analysts, the average 1-year price target for CPH is 19.58 CAD with a low forecast of 18.79 CAD and a high forecast of 21 CAD.

What is Cipher Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
28%

For the last 13 years the compound annual growth rate for Cipher Pharmaceuticals Inc's revenue is 19%. The projected CAGR for the next 3 years is 28%.

What is Cipher Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
68%

The compound annual growth rate of Cipher Pharmaceuticals Inc's operating income for the next 2 years is 68%.

What is Cipher Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
21%

The compound annual growth rate of Cipher Pharmaceuticals Inc's net income for the next 3 years is 21%.

Back to Top